Lumify (OTC)

Lumify (OTC)

Generic: Brimonidine tartrate 0.025%

Lumify (OTC)
DOSAGE 1gtt in the affected eye(s) every 6-8 hours
GENERIC bimatoprost 0.03%
SIZE 2.5mL, 7mL
INDICATIONS Red reliever OTC
MECHANISM OF ACTION adrenergic receptor agonist (primarily alpha-2)
MICROBIOLOGY Selectively constricts venules
CONTRAINDICATIONS & WARNINGS Hypersensitivity to any component of the product | At higher concentrations brimonidine is known to cause 10–20% rate of allergic conjunctivitis, conjunctival hyperemia, oral dryness, foreign body sensation
PEDIATRIC USE Children 5 years of age and over
PREGNANCY Category B (Alphagan) No teratogenicity in rats at 360 times the normal human dosage.
NOTE BAK preserved
Wait at least 10 minutes before re-inserting contact lenses after use. Caution | Usage can mask the progression of underlying pathology.